Market announcements

NZX/ASX Market Release

 Overview for the year ended 30 June 2017 (NZ$)

• Total revenue of $549.5 million – an increase of 56% over the prior corresponding period (pcp)
• EBITDA1 of $141.2 million – 159% ahead of the pcp
• EBITDA to sales margin of 26%, up from 15% on pcp
• Net profit after tax of $90.6 million – 198% ahead of the pcp
• Basic earnings per share (EPS) of 12.7 cents, an increase of 186% on pcp
• Operating cash flow of $99.9 million and a cash balance of $121.0 million at year end
• Continued strong growth in sales and market share for a2 Platinum® infant formula in Australia and China
• Sales growth of a2 Milk™ branded fresh milk and milk powders in Australia
• Increased investment in building brand awareness in the United States (US)
• Positive operating earnings in the United Kingdom (UK)
• Development of a broader nutritional products strategy and a new focus on emerging

 

To view the NZX Appendix 1  2017, please click here

To view the full year results commentary 2017, please click here

To view the 2017 Annual Report, please click here

To view the 2017 Annual Report (single page for printing), please click here

To view the ASX Appendix 4G 2017, please click here

To view the ASX Appendix 4E 2017, please click here